Results 91 to 100 of about 2,630,235 (212)

Ethical justification of single-blind and double-blind placebo-controlled response tests in neuropathic pain and N-of-1 treatment paradigm in clinical settings

open access: yesJournal of Pain Research, 2019
Jan M Keppel Hesselink,1 David J Kopsky,2 Arun K Bhaskar3 1Institute for Neuropathic Pain, Bosch en Duin, The Netherlands; 2Institute for Neuropathic Pain, Amsterdam, The Netherlands; 3Pain Management Centre, Charing Cross Hospital Imperial Healthcare ...
Keppel Hesselink JM   +2 more
doaj  

Double-blind, randomized, double-dummy clinical trial comparing the efficacy of ketorolac trometamol and naproxen for acute low back pain

open access: yesDrug Design, Development and Therapy, 2016
Pérola Grinberg Plapler,1 Morton Aaron Scheinberg,2 Christina da Cunha Ecclissato,3 Monalisa Fernanda Bocchi de Oliveira,3 Roberto Bleuel Amazonas31Orthopedic and Traumatology Institute of Clinical Hospital, University of São Paulo ...
Plapler PG   +4 more
doaj  

Double Blind Imaging with Generative Modeling [PDF]

open access: yesarXiv
Blind inverse problems in imaging arise from uncertainties in the system used to collect (noisy) measurements of images. Recovering clean images from these measurements typically requires identifying the imaging system, either implicitly or explicitly.
arxiv  

double blind test

open access: yes, 2020
double blind ...
openaire   +1 more source

Antibiotic treatment of epidemic bronchiolitis--a double-blind trial. [PDF]

open access: bronze, 1966
C. M. B. Field   +4 more
openalex   +1 more source

Trasicor in Angina Pectoris: a Double-blind Trial [PDF]

open access: bronze, 1969
Diane Wilson   +3 more
openalex   +1 more source

Prospective, double-blind, randomized controlled trial of electrophysiologically guided femoral nerve block in total knee arthroplasty

open access: yesTherapeutics and Clinical Risk Management, 2013
Yoon Seok Youm,1 Sung Do Cho,1 Chang Ho Hwang21Department of Orthopedic Surgery, 2Department of Physical Medicine and Rehabilitation, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Republic of KoreaBackground: The purpose of ...
Youm YS, Cho SD, Hwang CH
doaj  

Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial

open access: yesThe Lancet, 2017
J. Bruix   +23 more
semanticscholar   +1 more source

Dear reviewer: double blind, blind or open review?

open access: yesRevista Brasileira de Farmácia Hospitalar e Serviços de Saúde, 2019
Angelita C. Melo
doaj   +1 more source

Home - About - Disclaimer - Privacy